Quarterly report · Q1
4578.TEDINET S100TCFM
Period2024-01-01 → 2024-03-31
Filed2024-04-30
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥519.5bn | 2024-01-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥2.02T | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥448.3bn | 2023-01-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Operating income | ¥92.0bn | 2024-01-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥76.8bn | 2023-01-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥100.1bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥142.7bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥79.2bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥77.4bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥121.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥61.4bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥78.9bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥62.7bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥3.45T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥3.36T | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥3.13T | at 2023-03-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥894.5bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥924.9bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.56T | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.44T | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.32T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.26T | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥2.51T | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.39T | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.28T | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥411.6bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥513.3bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥477.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥471.6bn | at 2022-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥36.4bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥283.2bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥71.9bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥91.5bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥190.5bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥35.8bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥58.7bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥60.3bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥32.7bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥142.59 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥224.1 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥113.2 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥142.59 | 2024-01-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥224.1 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥113.18 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 72.8% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.2% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 72.8% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-03-31 | ¥27.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-03-31 | ¥26.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥872m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-03-31 | ¥1.9bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-03-31 | −¥881m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-03-31 | −¥881m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥10.8bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥7.3bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥7.3bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥4.3bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥126.2bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥126.2bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥6m |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥16.8bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥359.6bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥359.6bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥79.8bn |
| —segment total | revenue | 2024-01-01 → 2024-03-31 | ¥520.4bn |
| —segment total | revenue external | 2024-01-01 → 2024-03-31 | ¥519.5bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥881m |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | ¥102.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-03-31 | ¥27.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-03-31 | ¥26.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥723m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | ¥3.1bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | −¥742m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | −¥742m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥12.9bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥4m |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥104.0bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥104.0bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥13m |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥10.8bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥309.5bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥309.5bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥73.6bn |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥449.1bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥448.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥742m |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥89.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 694
| Item | Context | Value | Unit |
|---|---|---|---|
| Dividends ss IFRS | CurrentYTDDuration | -33574000000 | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember | － | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | － | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | -5000000 | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | 5000000 | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration | － | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember | － | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | -662000000 | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | － | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | － | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration | － | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember | － | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | -662000000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | -32567000000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | -1007000000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration | -33575000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | 249775000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember | -16000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_OtherComponentsOfEquityIFRSMember | 301643000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember | 2511586000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_NonControllingInterestsIFRSMember | 43668000000 | JPY |
| Equity IFRS | CurrentQuarterInstant | 2555254000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 79242000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 100079000000 | JPY |
| Depreciation and amortization ope cf IFRS | Prior1YTDDuration | 22814000000 | JPY |
| Depreciation and amortization ope cf IFRS | CurrentYTDDuration | 26064000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | Prior1YTDDuration | 211000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | CurrentYTDDuration | 125000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | Prior1YTDDuration | -5640000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | CurrentYTDDuration | -7387000000 | JPY |
| Finance income ope cf IFRS | Prior1YTDDuration | -3884000000 | JPY |
| Finance income ope cf IFRS | CurrentYTDDuration | -10092000000 | JPY |
| Finance costs ope cf IFRS | Prior1YTDDuration | 1421000000 | JPY |
| Finance costs ope cf IFRS | CurrentYTDDuration | 2034000000 | JPY |
| Decrease increase in inventories ope cf IFRS | Prior1YTDDuration | -14474000000 | JPY |
| Decrease increase in inventories ope cf IFRS | CurrentYTDDuration | -18214000000 | JPY |
| Decrease increase in trade and other receivables2 ope cf IFRS | Prior1YTDDuration | 38747000000 | JPY |
| Decrease increase in trade and other receivables2 ope cf IFRS | CurrentYTDDuration | 22215000000 | JPY |
| Increase decrease in trade and other payables2 ope cf IFRS | Prior1YTDDuration | -27511000000 | JPY |
| Increase decrease in trade and other payables2 ope cf IFRS | CurrentYTDDuration | -17851000000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1YTDDuration | -2390000000 | JPY |
| Other changes in working capital ope cf IFRS | CurrentYTDDuration | -24342000000 | JPY |
| Subtotal ope cf IFRS | Prior1YTDDuration | 88535000000 | JPY |
| Subtotal ope cf IFRS | CurrentYTDDuration | 72631000000 | JPY |
| Interest and dividends received ope cf IFRS | Prior1YTDDuration | 2960000000 | JPY |
| Interest and dividends received ope cf IFRS | CurrentYTDDuration | 2932000000 | JPY |
| Interest paid ope cf IFRS | Prior1YTDDuration | -821000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |